Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Kineticos Life Sciences Announces Tom Pitler as President and Chief Operating Officer | ||
| By: PR Newswire Association LLC. - 12 May 2022 | Back to overview list |
|
|
RALEIGH, N.C., May 12, 2022 /PRNewswire/ -- Kineticos Life Sciences announced today that Thomas A. Pitler, Ph.D. has joined as President and Chief Operating Officer. Dr. Pitler joins Kineticos Life Sciences with 20+ years of experience as a senior executive in the biopharmaceutical industry. Dr. Pitler brings extensive experience in pharmaceutical research, clinical development, market analysis, business development, financing, and M&A transactions.
Dr. Pitler joins Kineticos Life Sciences with 20+ years of experience as a senior executive in the biopharma industry Kineticos Life Sciences is a life sciences consulting firm that represents centers of excellence in cell & gene therapy and oncology, combined with a vast depth of expertise in driving strategy and growth for companies in these areas. With experience in hundreds of projects with biotechs, contract service companies, and investors, among others, we have built an incredible team of consultants, operating experts, and a network of KOLs, who bring unprecedented experience to the passionate, seamless collaborations we build with our clients. In this new role with Kineticos Life Sciences, Dr. Pitler's responsibilities will include long-term strategy, management of operations, and client interactions. Prior to joining Kineticos Life Sciences, Dr. Pitler ran an independent consulting practice, and prior to that was employed by Heron Therapeutics, VetMed Therapeutics, Capture Pharmaceuticals, Chimerix, Neurogen Corporation, and the University of Maryland School of Medicine. When asked about his new role at Kineticos Life Sciences, Dr. Pitler said, "I am delighted to join the Kineticos Life Sciences team. We get to work with world-class companies every day and help in the development and commercialization of truly exciting and novel technologies. I look forward to working with the team at Kineticos Life Sciences to help companies succeed in their mission and ultimately improve medical treatments and human health." Shailesh Maingi, Founder and Chairman of Kineticos Life Sciences, noted: "Tom has great experience working with a wide range of biopharmaceutical companies in scientific, management, and business development roles. His scientific background, business acumen, and deep knowledge of the industry will greatly aid in the service of our clients and in maintaining the highest quality of advisory services." Kineticos Ventures', the Venture Capital group within Kineticos, CEO Frank Lis adds "We are excited to have Tom as part of the Kineticos team. His experience and knowledge of the biotech industry will be integral as Kineticos Life Sciences looks to grow and invest in this space." Kineticos Life Sciences is excited to bring Dr. Pitler on as the President and Chief Operating Officer of Kineticos Life Sciences. With this new addition, Kineticos Life Sciences continues to strengthen its position as an industry leader in the Life Sciences. About Kineticos Life Sciences: Kineticos is an award-winning firm with a dual focus on providing advisory services and capital to emerging life sciences firms. Our mission is simple: to improve patient outcomes. Every day, we see how biotechs are changing the standards of care in medicine. With over 6,000 firms globally, biotechs are the catalysts of innovation in life sciences today; yet emerging companies often have limited resources to focus on strategy and capital, and addressing these challenges is at the core of our capabilities. Join us in our mission to improve patient outcomes by advancing the boundaries of scientific research, development, and commercialization. Paired with our Venture Capital group, Kineticos Ventures, Kineticos continues to invest in life sciences through both capital and strategy consulting. Contact:
SOURCE Kineticos 
|
||
|
||
 | Back to overview list | |
View original content to download multimedia: